http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004180045-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 |
| filingDate | 2004-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8699a42b7cb11d238f21784c161b2c06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07949e0071ff8f17501cbe824c967edd |
| publicationDate | 2004-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004180045-A1 |
| titleOfInvention | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G |
| abstract | Human plasma fractions substantially enriched in human immunoglobulin G, such as Cohn Fraction II+III, and optionally an antacid may be administered orally to patients suffering from a myriad of immune-mediated diseases, including rheumatoid arthritis, to treat the disease condition of those patients. Oral administration of Cohn Fraction II+III results in significant clinical improvement in the level of disease activity in patients with rheumatoid arthritis, for example. |
| priorityDate | 2001-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 344.